Imaging the Vasculature of Immunodeficient Mice Using Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-fluorodeoxyglucose Labeled Human Erythrocytes

Nuclear blood pool imaging using radiolabeled red blood cells has been used in the clinical setting for the evaluation of a number of medical conditions including gastrointestinal hemorrhage, impaired cardiac contractility, and altered cerebrovascular blood flow. Nuclear blood pool imaging is typica...

Full description

Bibliographic Details
Published in:	Bio-Protocol
Main Authors:	Shaowei Wang, Jung Choi
Format:	Article
Language:	English
Published:	Bio-protocol LLC 2019-10-01
Online Access:	https://bio-protocol.org/en/bpdetail?id=3391&type=0

Similar Items

Characteristics of malignant thyroid lesions on [18F] fluorodeoxyglucose (FDG)-Positron emission tomography (PET)/Computed tomography (CT)
by: Hatem Nasr, et al.
Published: (2021-01-01)

In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes.
by: Jung W Choi, et al.
Published: (2019-01-01)

False-positive 18-fluorodeoxyglucose positron emission tomography–computed tomography (FDG PET/CT) scans mimicking malignancies
by: Zehra Yasar, et al.
Published: (2015-02-01)

The 18F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer
by: Mihailović Jasna, et al.
Published: (2017-01-01)

Candida pyelonephritis on 18F-fluorodeoxyglucose positron emission tomography/computed tomography
by: Junwei Zhang, et al.
Published: (2016-10-01)

Neurolymphomatosis detected by 18F‐fluorodeoxyglucose‐positron emission tomography
by: Yoshikazu Hori, et al.
Published: (2020-07-01)

Value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in assessment of response to preoperative chemotherapy in pediatric sarcoma
by: Ahmed Mohamed Rashad, et al.
Published: (2019-09-01)

Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
by: Yoji YAMAGISHI, et al.
Published: (2019-11-01)

Benign uptake of 18F-fluorodeoxyglucose in the gallbladder on positron emission tomography-computed tomography
by: Riffat Hussain, et al.
Published: (2020-07-01)

Gallbladder lymphoma detected by 18F-fluorodeoxyglucose positron emission tomography
by: Alvin So, et al.
Published: (2020-10-01)

Fluorodeoxyglucose positron emission tomography (18F-FDG PET)-computed tomography (CT) in the initial staging of bladder cancer: a single institution experience
by: Mohammed Shahait, et al.
Published: (2023-07-01)

Clinical Utility of <sup>18</sup>Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (<sup>18</sup>F-FDG PET/CT) in Multivisceral Transplant Patients
by: Shao Jin Ong, et al.
Published: (2023-06-01)

Clinical utility of 18fluorodeoxyglucose positron emission tomography-computed tomography in rheumatology
by: Sirisha Kommireddy, et al.
Published: (2021-01-01)

18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging of leiomyomatosis peritonealis disseminata
by: Alex Cheen Hoe Khoo, et al.
Published: (2021-07-01)

Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in anorectal melanoma
by: Ajinkya N. Bakare, et al.
Published: (2021-07-01)

18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Infected Polycystic Kidney Disease
by: Anna Paschali, et al.
Published: (2015-01-01)

An overview of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in giant cell arteritis
by: Thomas Thibault, et al.
Published: (2024-10-01)

The Role of Preoperative 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Retroperitoneal Sarcoma
by: Sung Jun Jo, et al.
Published: (2022-05-01)

(18)F‐fluorodeoxyglucose uptake by positron emission tomography in patients with IPAH and CTEPH
by: Celik Sumer, et al.
Published: (2024-04-01)

Comparison of <sup>18</sup>F-fluorothymidine Positron Emission Tomography/Computed Tomography and <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
by: Mio Mori, et al.
Published: (2022-10-01)

18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging review of benign lesions of the thorax
by: Reddy Ravikanth
Published: (2021-03-01)

Irritated seborrhoeic keratosis masquerading as malignancy on 18F-fluorodeoxyglucose positron emission tomography–computed tomography
by: Punit Sharma
Published: (2021-01-01)

18F fluorodeoxyglucose positron-emission tomography–computed tomography in the diagnosis of brachial plexopathy in carcinoma breast
by: Suma Tammineni Medara, et al.
Published: (2022-01-01)

Multiple lytic lesions on F-18 fluorodeoxyglucose positron emission tomography/computed tomography not always metastatic?
by: Averilicia Passah, et al.
Published: (2018-01-01)

The role of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in the differential diagnosis of pericardial disease
by: Cheol Won Hyeon, et al.
Published: (2020-12-01)

Diagnostic utility of positron emission tomography-computed tomography and indications for 18F-Fluorodeoxyglucose and amyloid-tracers
by: Maria Lucia Calcagni, et al.
Published: (2018-11-01)

The Utility of [18]F-Fluorocholine Positron Emission Computed Tomography and [18]F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Evaluating Breast Cancer Phenotypes: A Pilot Study
by: Mohd Hazeman Zakaria, et al.
Published: (2024-06-01)

18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging evaluation of chorea
by: Nobuyuki Ishii, et al.
Published: (2018-09-01)

Tuberculous encephalitis with aphemia detected only by 18F-fluorodeoxyglucose-positron emission tomography
by: Boby Varkey Maramattom, et al.
Published: (2019-01-01)

Synthesis of 18fluoride-fluorodeoxyglucose and its clinical applications in positron emission tomography/computed tomography
by: Rajeev Kumar, et al.
Published: (2022-09-01)

Xanthogranulomatous cholecystitis mimicking gallbladder cancer on 18F-fluorodeoxyglucose positron emission tomography/computed tomography scan
by: Nitin Gupta, et al.
Published: (2021-03-01)

The accuracy of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of bone lesions of undetermined origin
by: Cuneyt Tamam, et al.
Published: (2016-04-01)

Positive 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 20 Years after Talc Pleurodesis
by: Supriya A. Bhupathy, et al.
Published: (2022-12-01)

Assessment of Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Carcinoma of Unknown Primary
by: S. A. Yaremenko, et al.
Published: (2021-09-01)

Detection of muscle metastases on 18F-fluorodeoxyglucose positron emission tomography/computed tomography scan in 13 cases
by: Abderrahim Doudouh, et al.
Published: (2020-10-01)

A case report of calcific aterosclerosis demonstrated on 18-F-fluorodeoxyglucose positron emission tomography/computed tomography
by: Antonella Laria, et al.
Published: (2021-10-01)

[18F]fluorodeoxyglucose positron emission tomography/computed tomography characteristics of primary mediastinal germ cell tumors
by: Koeun Lee, et al.
Published: (2023-10-01)

Extranodal involvement of posttransplant lymphoproliferative disorder detected on 18F‐fluorodeoxyglucose‐positron emission tomography/computed tomography
by: Bojun Wang, et al.
Published: (2023-06-01)

Primary spindle cell sarcoma of the prostate and 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography findings
by: Hakan Öztürk
Published: (2015-01-01)

Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Susanna Nuvoli, et al.
Published: (2018-02-01)